00:00
Growing Money
Growing Money
USD/RUB
EUR/RUB
Releases

GERD Device Market Poised for Growth as Diagnostic Precision Takes Lead

The global market for gastroesophageal reflux disease (GERD) devices is projected to expand from USD 1.3 billion in 2026 to USD 1.9 billion by 2036. This steady growth, forecasted at a 3.9% CAGR, signals a shift toward objective diagnostic confirmation and minimally invasive surgical interventions over traditional pharmaceutical management.

Healthcare providers are increasingly prioritizing evidence-based reflux management, driving demand for specialized diagnostic tools such as manometry, pH monitoring systems, and advanced upper GI visualization. As clinical requirements evolve, the market has moved beyond simple hardware sales, favoring suppliers who integrate procedural training, service reliability, and efficient clinical workflows into their offerings.

Minimally invasive procedures, particularly magnetic sphincter augmentation and fundoplication, are becoming the preferred standard for patients unresponsive to conventional medication. While hospitals currently command a 60% market share, the complexity of these interventions necessitates significant investments in infrastructure and specialized surgical expertise. Market expansion remains most robust in the United States, which leads growth with a 5.2% CAGR, followed by emerging demand in India and China. Despite high procedure costs and strict regulatory hurdles, the sector is transitioning into a high-value care environment where diagnostic accuracy and patient-friendly technology define long-term commercial success.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!